Pharmacological screening of Malian medicinal plants used against epilepsy and convulsions

Journal of Ethnopharmacology

Volumn 121, Issue 3, 2009, Pages 472-475

  Pedersen, Mikael E ^a   Vestergaard, Henrik T ^a   Hansen, Suzanne L ^a   Bah, Sekou ^b   Diallo, Drissa ^b   Jäger, Anna K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Institut National de Recherche en Sante Publique Mali   (Mali)

Author keywords

Cortical wedge preparation; Epilepsy; GABA; Malian traditional medicine

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCHORNEA CORDIFOLIA EXTRACT; BALANITES AEGYPTIACUS EXTRACT; BENZODIAZEPINE RECEPTOR; BRIDELIA FERRUGINEA EXTRACT; BURKEA AFRICANA EXTRACT; FLUEGGEA VIROSA EXTRACT; FLUMAZENIL; GUIERA SENEGALENSIS EXTRACT; OZOROA INSIGNIS EXTRACT; PENTETRAZOLE; PLANT EXTRACT; PSEUDOCEDRALA KOTSCHYI EXTRACT; PSOROSPERMUM SENEGALENSE EXTRACT; PTELEOPSIS SUBEROSA EXTRACT; TERMINALIA MACROPTERA EXTRACT; TRITIUM; UNCLASSIFIED DRUG;

ALCHORNEA CORDIFOLIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BALANITES AEGYPTIACUS; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; BRAIN CORTEX; BRIDELIA FERRUGINEA; BURKEA AFRICANA; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; EPILEPSY; EPILEPTIC DISCHARGE; EXPERIMENTAL MODEL; FLUEGGEA VIROSA; GUIERA SENEGALENSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MALI; MEDICINAL PLANT; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OZOROA INSIGNIS; PSEUDOCEDRALA KOTSCHYI; PSOROSPERMUM SENEGALENSE; PTELEOPSIS SUBEROSA; ROTAROD TEST; TERMINALIA MACROPTERA; TRADITIONAL MEDICINE;

ANIMALS; ANTICONVULSANTS; EPILEPSY; MALE; MALI; MICE; PENTYLENETETRAZOLE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RECEPTORS, GABA-A; SEIZURES;

FLUEGGEA VIROSA; MALIA; MUS;

EID: 58149247787     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.11.006     Document Type: Article

References (30)

1. Adjanohoun E.J., Ahyi M.R.A., Ake Assi L., Akpagana K.C., and Hadjia E. Contribution aux études ethnobotaniques et floristiques au Togo. In: Adjanohoun E.J. (Ed). Médecine Traditionnelle et Pharmacopée (1986), ACCT, Paris pp. 217, 259-261
2. Adjanohoun, E.J., Ake Assi, L., 1979. Contribution au recensement des plantes médicinales de Côte d'Ivoire. Centre national de floristique, Abidjan, Côte d'Ivoire.
3. Adjanohoun E.J., Ake Assi L., Chettry K.S., Chongoseng L., Eyne J., Gassitu S.N., Gondote E.N., Keita A., and Kandogobo B. Contribution aux études ethnobotaniques et floristiques en République Populaire du Bénin. In: Adjanohoun E.J. (Ed). Médecine Traditionnelle et Pharmacopée (1989), ACCT, Paris p. 321
4. Amos S., Kolawole E., Akah P., Wambebe C., and Gamaniel K. Behavioral effects of the aqueous extract of Guiera senegalensis in mice and rats. Phytomedicine 8 (2001) 356-361
5. Arborio S., Jaffre Y., Farnarier G., Doumbo O., and Dozon J.P. Kirikirimasien (epilepsy) in Mali: etiologic and nosologic dimensions. Medecine Tropicale 59 (1999) 176-180
6. A-benzodiazepine receptor binding activities of five plants used in traditional medicine in Mali, West Africa. Journal of Ethnopharmacology 110 (2007) 451-457
7. Cacazos J.E., and Sanchez R. Pathophysiology of seizures and epilepsy. In: Rho J.M., Sankar R., and Cavazos J.E. (Eds). Epilepsy (2004), Marcel Dekker Inc., USA
8. Carpio A., Bharucha N.E., Jallon P., Beghi E., Campostrini R., Zorzetto S., and Mounkoro P.P. Mortality of epilepsy in developing countries. Epilepsia 46 (2005) 28-32
9. De Leo M., Braca A., Sanogo R., Cardile V., DeTommasi N., and Russo A. Antiproliferative activity of Pteleopsis suberosa leaf extract and its flavonoid components in human prostate carcinoma cells. Planta Medica 72 (2006) 604
10. Diallo D., Hveem B., Mahmoud M.A., Berge G., Paulsen B.S., and Maiga A. An ethnobotanical survey of herbal drugs of Gourma District, Mali. Pharmaceutical Biology 37 (1999) 80-91
11. Ebert B., Mikkelsen S., Thorkildsen C., and Borgbjerg F.M. Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. European Journal of Pharmacology 333 (1997) 99-104
12. Ebert B., Storustovu I., Mortensen M., and Frolund B. Characterization of GABA(A) receptor ligands in the rat cortical wedge preparation: evidence for action at extrasynaptic receptors?. British Journal of Pharmacology 137 (2002) 1-8
13. Farnarier G., Diop S., Coulibaly B., Arborio S., Dabo A., Diakite M., Traore S., Banou A., Nimaga K., Vaz T., and Doumbo O. Onchocercose et épilepsie. Enquëte épidèmiologique au Mali. Médecine tropical 60 (2000) 151-155
14. Hansen S.L., Sperling B.B., and Sánchez C. Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice. Progress in Neuropsychopharmacology & Biological Psychiatry 28 (2004) 105-113
15. Harrison N.L., and Simmonds M.A. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Research 323 (1984) 287-292
16. Harrison N.L., and Simmonds M.A. Quantitative studies on some antagonists of N-methyl d-aspartate in slices of rat cerebral cortex. British Journal of Pharmacology 84 (1985) 381
17. Heinemann U., Kann O., and Schuchmann S. An overview of in vitro seizure models in acute and organotypic slices. In: Pitkänen A., Schwartzkroin P.A., and Moshé S.L. (Eds). Models of Seizures and Epilepsy (2006), Elsevier Academic Press, Burlington, San Diego, London 35-45
18. Huang R.-Q., Bell-Horner C.L., Dibas M.I., Covey D.F., Drewe J.A., and Dillon G.H. Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABAA) receptors: mechanism and site of action. Journal of Pharmacology and Experimental Therapeutics 298 (2001) 986-995
19. Kahnberg P., Lager E., Rosenberg C., Schougaard J., Camet L., Sterner O., Nielsen E.O., Nielsen M., and Liljefors T. Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABA(A) receptor. Journal of Medicinal Chemistry 45 (2002) 4188-4201
20. Mason C.R., and Cooper R.M. A permanent change in convulsive threshold in normal and brain-damaged rats with repeated small doses of Pentylenetetrazol*. Epilepsia 13 (1972) 663-674
21. Nadkarni S., LaJoie J., and Devinsky O. Current treatments of epilepsy. Neurology 64 (2005) S2-S11
22. Neuwinger, H.D., 1998. Afrikanische Arzneipflanzen und Jagdgifte: Chemie, Pharmakologie, Toxikologie; ein Handbuch für Pharmazeuten, Mediziner, Chemiker und Biologen. Wissenschaftliche Verlagsgesellschaft mBH, Stuttgart.
23. Olsen R.W. The GABA postsynaptic membrane receptor-ionophore complex. Molecular and Cellular Biochemistry 39 (1981) 261-279
24. Pedersen, M.E., Vestergaard, H.T., Stafford, G.I., van Staden, J., Jäger, A.K., 2008. The effect of extracts of Searsia species on epileptiform activity in slices of the mouse cerebral cortex. Journal of Ethnopharmacology 119, 538-41.
25. Racine R.J. Modification of seizure activity by electrical brain stimulation. II. Motor seizure. Electroencephalography and Clinical Neurophysiology 32 (1972) 281-294
26. Rang H.P., Dale M.M., Ritter J.M., and Moore P.K. Pharmacology (2007), Churchill Livingstone, Edinburgh
27. Richens A., and Perucca E. Clinical pharmacology and medical treatment. In: Laidlaw J., Richens A., and Chadwick D. (Eds). A Textbook of Epilepsy (1993), Churchill Livingstone, Edinburgh 495-560
28. Risa J., Risa A., Adsersen A., Gauguin B., Stafford G.I., van Staden J., and Jäger A.K. Screening of plants used in southern Africa for epilepsy and convulsions in the GABAA-benzodiazepine receptor assay. Journal of Ethnopharmacology 93 (2004) 177-182
29. Smith M., Wilcox K.S., and White H.S. Discovery of antiepileptic drugs. Neurotherapeutics 4 (2007) 12-17
30. Svenningsen A.B., Madsen K.D., Liljefors T., Stafford G.I., van Staden J., and Jäger A.K. Biflavones from Rhus species with affinity for the GABAA/benzodiazepine receptor. Journal of Ethnopharmacology 103 (2006) 276-280